Oragenics
OGEN
10 hedge funds and large institutions have $182K invested in Oragenics in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
5% more capital invested
Capital invested by funds: $174K → $182K (+$8.64K)
0% more funds holding
Funds holding: 10 → 10 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.01% less ownership
Funds ownership: 0.09% → 0.08% (-0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$24.5K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.4K |
| 3 |
Renaissance Technologies
New York
|
+$2.7K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$100 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$899 |
| 2 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$116 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
BlackRock
New York
| $65.8K | – | – | – |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $58.8K | +$24.5K | +245 | +59% |
|
|
3
Renaissance Technologies
New York
| $40K | +$2.7K | +27 | +6% |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $8.89K | +$3.4K | +34 | +52% |
|
5
Fidelity Investments
Boston,
Massachusetts
| $7.73K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $380 | -$899 | -9 | -69% |
|
7
Bank of America
Charlotte,
North Carolina
| $336 | – | – | – |
|
|
8
Osaic Holdings
Scottsdale,
Arizona
| $67 | +$100 | +1 | New |
|
9
Wells Fargo
San Francisco,
California
| $59 | – | – | – |
|
|
WWM
10
Wolff Wiese Magana
Carslbad,
California
| $51 | – | – | – |
|
|
CAM
11
Chesapeake Asset Management
New York
| $8 | – | – | – |
|
|
TFG
12
Team Financial Group
Temecula,
California
| $3 | – | – | – |
|
|
13
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$116 | -1 | Closed |
|
OGEN Hedge Fund Activity: Q3 2023 in Review
10 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q3 2023, worth a combined $182K — up 5% from $174K a quarter earlier.
Fund positioning in OGEN was balanced in Q3 2023: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $24.5K. The largest seller was UBS Group, cutting an estimated $899.
- 10 institutional investors held Oragenics (OGEN) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $182K of Oragenics stock for Q3 2023, up 5% quarter-over-quarter.
- 1 fund opened new Oragenics positions in Q3 2023 and 1 closed out, a net change of 0 holders.
- The largest Oragenics buyer in Q3 2023 was Geode Capital Management, an estimated $24.5K added.
- The largest Oragenics seller in Q3 2023 was UBS Group, an estimated $899 sold.
Based on aggregated 13F filings for Q3 2023.